INM reverse split history: InMed Pharmaceuticals Inc. Common Shares
Listed on Nasdaq. Split dates, ratios and the filings behind them.
On the reverse split lists now
- Stage locked1-for-10effective Thu, Nov 5, 2026
Source: 8-K, filed Nov 5, 2026
Stage, approval route, meeting and approval dates are part of SplitScanner.
Unlock with SplitScannerSplit history
| Effective date | Direction | Ratio | Status |
|---|---|---|---|
| Nov 5, 2026 | Reverse | 1 to 10 | Took effect |
| Nov 14, 2024 | Reverse | 1 to 20 | Took effect |
| Sep 7, 2022 | Reverse | 1 to 25 | Took effect |
Exchange listing context
- equity deficiencyNASDAQfiled Sep 18, 2026
Listing Rule 5550(b)(1). Estimated compliance period ends Nov 2, 2026. Not marked resolved in the index.
SEC filing 000121390026101492 - bid price deficiencyNASDAQfiled Mar 30, 2026
Listing Rule 5550(a)(2). Estimated compliance period ends Sep 26, 2026. Not marked resolved in the index.
SEC filing 000106299326001697
Exchange deficiency notices Signal8 detected in 8-K Item 3.01 filings. No notice listed means none was found in that index, not that the company is in compliance.
Approval timeline
Locked2 tracked episodes on record. Every filing and step from proposal to effective date.
Included with SplitScanner ($9.99 a month) and Signal8 Pro.
Unlock with SplitScannerHow it traded after each split
Locked3 executed reverse splits on record. The move over the 30 days after each one, on one split basis.
Included with SplitScanner ($9.99 a month) and Signal8 Pro.
Unlock with SplitScannerFloat before and after
Locked102 float samples on record. Float around each split, from the daily float record.
Included with SplitScanner ($9.99 a month) and Signal8 Pro.
Unlock with SplitScannerAI summaries of the filings
Locked6 analysed filing or releases on record. Plain-English readings of each filing and press release about the split, from the Signal8 analysis.
Included with SplitScanner ($9.99 a month) and Signal8 Pro.
Unlock with SplitScannerSplit dates and ratios come from the market split calendar and are cross-checked against a second source; a row only one source evidences is marked unconfirmed. Funds, ETFs and other non-equity securities are excluded. The index is keyed by ticker symbol, so a company that changed symbol between splits appears under each symbol.